Interferon complex and medicinal use thereof

Details Interferon complex and medicinal use thereof Interferon complex and medicinal use thereof

2005-11-29

2005-11-29

Azpuru, Carlos A. (Department: 1615)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Implant or insert

Reexamination Certificate

active

06969524

ABSTRACT:
An object of the present invention is to provide modified IFN so that duration of IFN in blood is prolonged and IFN acts specifically on tissues having neovasculature, particularly tumors or ophthalmic tissues having neovasculature. The present invention provides an interferon-dextran complex obtained by mixing interferon with dextran having chelate ligands in the presence of a metal ion.

REFERENCES:
patent: 4041152 (1977-08-01), Chany et al.
patent: 5382657 (1995-01-01), Karasiewicz et al.
patent: 0 123 291 (1984-10-01), None
patent: 6-192300 (1994-07-01), None
patent: WO 95/13090 (1995-05-01), None
patent: WO 97/18832 (1997-05-01), None
patent: WO 99/32139 (1999-07-01), None
patent: WO 99/32140 (1999-07-01), None
Y. Tabata et al, “Targeting of tumor necrosis factor to tumor by use of dextran and metal coordination”,J. Controlled Release, vol. 59, No. 2, pp. 187-196 & cover page (1999).
Okushin et al,Liver, vol. 36, p. 735 (1995) (with English language Abstract).
Y. Tabata et al, “Simple Mixing of IFN with Polysaccharide Having High Liver Affinity Enables IFN to Target to the Liver”,J. Interferon and Cytokine Research, vol. 19, pp. 287-292 (1999).
Y.A. Sidky et al, “Inhibition of Angiogenesis by Interferon: Effects on Tumor- and Lymphocyte-induced Vascular Responses”,Cancer Res.,vol. 47, pp. 5155-5161 (Oct. 1987).
W.E. Fung, “Interferen Alpha 2a for Treatment of Age-Related Macular Degeneration”,Am. J.Ophthalmology, vol. 112, No. 3, pp. 349-350 (1992).
J.W. Miller et al, “Regression of Experimental Iris Neovascularization with Systemic Alpha-interferon”,Ophthamology, vol. 100, No. 1, pp. 9-14 (1992).
J. Wakelee-Lynch, “Interferon May Offer First Drug Therapy for Diabetic Retinopathy”,Diabetes Care, vol. 15, No. 22, pp. 300-301 (Feb. 1992).
T. Yamaoka et al, “Body Distribution Profile of Polysaccharides after Intravenous Administration”,Drug Delivery, vol. 1, pp. 75-82 (1993).

Affiliated with

Also associated with

Rating

Interferon complex and medicinal use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Interferon complex and medicinal use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Interferon complex and medicinal use thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3467574